Citation: | FU Xin, DING Fang, LU Jian-hua, LIU Yong-gang, YAN Hui-min. Risk factors and predictive model for the progression of HBV-related acute-on-chronic liver failure[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(7): 864-868. doi: 10.16462/j.cnki.zhjbkz.2021.07.023 |
[1] |
Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67(12): 2181-2191. DOI: 10.1136/Gutjnl-2017-314641.
|
[2] |
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 中华肝脏病杂志, 2019, 27(1): 18-26. DOI: 10.3760/cma.j.issn.1007-3418.2019.01.006.
Liver Failure and Artificial Liver Group, Chinese Society of lnfectious Diseases, Chinese Medical Associationm, Severe Liver Disease and Amficial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment ofliver failure[J]. Chin J Hepatol, 2019, 27(1): 18-26. DOI: 10.3760/cma.j.issn.1007-3418.2019.01.006.
|
[3] |
Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure[J]. Medicine (Baltimore), 2017, 96(24): e7142. DOI: 10.1097/md.0000000000007142.
|
[4] |
Dominguez M, Rincón D, Abraldes JG, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis[J]. Am J Gastroenterol, 2008, 103(11): 2747-2756. DOI: 10.1111/j.1572-0241.2008.02104.x.
|
[5] |
龙骏, 林世德, 刘璐璐, 等. MELD相关评分模型对重症化慢性乙型肝炎患者进展为肝衰竭的预测价值[J]. 中国医学创新, 2019, 16(33): 153-157. DOI: 10.3969/j.issn.1674-4985.2019.33.039.
Long J, Lin SD, Liu LL, et al. Predictive value of MELD-based models predict for liver failure in patients with acute exacerbation of chronic hepatitis B patients[J]. Medical Innovation of China, 2019, 16(33): 153-157. DOI: 10.3969/j.issn.1674-4985.2019.33.039.
|
[6] |
张辉艳, 谢桂娟, 陈晴, 等. 乙型肝炎病毒相关慢加急性肝衰竭前期的诊断标准探讨[J]. 中华肝脏病杂志, 2016, 24(5): 363-367. DOI:103760/cma.j.jssn.1007-3418.2016.05.010.
Zhang HY, Xie GJ, Chen Q, et al. Diagnostic criteria for HBV-related acute-on-chronic pre-fiver failure[J]. Chin J Hepatol, 2016, 24(5): 363-367. DOI:103760/cma.j.jssn.1007-3418.2016.05.010.
|
[7] |
李琴, 贾继东, 王宝恩. 凝血酶原时间及凝血因子在肝病中的应用[J]. 中华肝脏病杂志, 2004, 12(12): 767-768. doi: 10.3760/j.issn:1007-3418.2004.12.024
Li Q, Jia JD, Wang BE. The clinical application of prothrombin time and coagulation factors in liver diseases [J]. Chin J Hepatol, 2004, 12(12): 767-768. doi: 10.3760/j.issn:1007-3418.2004.12.024
|
[8] |
Jie Y, Gong J, Xiao C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure[J]. Biomed Res Int, 2018: 7394904. DOI: 10.1155/2018/7394904.
|
[9] |
杜娟, 王慧, 何敏, 等. 基于营养风险评估的个体化营养支持治疗对重症患者营养状态及预后的效果观察[J]. 广西医科大学学报, 2019, 36(9): 1518-1522. DOI: 10.16190/j.cnki.45-1211/r.2019.09.030.
Du J, Wang H, He M, et al. Effect of individualized nutritional support treatment based on nutritional risk assessment on nutritional status and prognosis of critically ill patients[J]. Journal of Guangxi Medical University, 2019, 36(9): 1518-1522. DOI: 10.16190/j.cnki.45-1211/r.2019.09.030.
|